TR200300510A2 - Dağılan alendronat mikropartikül formülasyonu - Google Patents

Dağılan alendronat mikropartikül formülasyonu

Info

Publication number
TR200300510A2
TR200300510A2 TR2003/00510A TR200300510A TR200300510A2 TR 200300510 A2 TR200300510 A2 TR 200300510A2 TR 2003/00510 A TR2003/00510 A TR 2003/00510A TR 200300510 A TR200300510 A TR 200300510A TR 200300510 A2 TR200300510 A2 TR 200300510A2
Authority
TR
Turkey
Prior art keywords
alendronate
dispersing
microparticle formulation
glass
water
Prior art date
Application number
TR2003/00510A
Other languages
English (en)
Inventor
�Ner Levent
��Fter �M�T
Sakarya N�Sa
T�Rkyilmaz Al�
Original Assignee
Sanovel �La� Sanay� Ve T�Caret A.�.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel �La� Sanay� Ve T�Caret A.�. filed Critical Sanovel �La� Sanay� Ve T�Caret A.�.
Priority to TR2003/00510A priority Critical patent/TR200300510A2/tr
Priority to US10/824,695 priority patent/US20040208925A1/en
Priority to AT04760192T priority patent/ATE399003T1/de
Priority to EP04760192A priority patent/EP1617826B1/en
Priority to DE602004014606T priority patent/DE602004014606D1/de
Priority to ES04760192T priority patent/ES2308215T3/es
Priority to DK04760192T priority patent/DK1617826T3/da
Priority to PL04760192T priority patent/PL1617826T3/pl
Priority to SI200430813T priority patent/SI1617826T1/sl
Priority to PCT/TR2004/000024 priority patent/WO2004096189A2/en
Priority to PT04760192T priority patent/PT1617826E/pt
Publication of TR200300510A2 publication Critical patent/TR200300510A2/tr
Priority to CY20081100921T priority patent/CY1108298T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu bulus alendronatin özefagus ve midede ortaya çikabilecek yan etkilerini azaltmak için oral yolla bir bardak suda disperse edilerek uygulanan tükrük PH'sina dayanikli polimer ile kaplanmis alendronat mikropartikülleri, tedavi edici miktarda aljinik asit veya sodyum aljinat ile en az bir tatlandirici veya karisimini içeren paket formülasyonun hazirlanmasi ile iliskilidir.
TR2003/00510A 2003-04-18 2003-04-18 Dağılan alendronat mikropartikül formülasyonu TR200300510A2 (tr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
TR2003/00510A TR200300510A2 (tr) 2003-04-18 2003-04-18 Dağılan alendronat mikropartikül formülasyonu
US10/824,695 US20040208925A1 (en) 2003-04-18 2004-04-14 Dispersible alendronate microparticle formulation
ES04760192T ES2308215T3 (es) 2003-04-18 2004-04-19 Formulacion dispersable de microparticulas de alendronato.
EP04760192A EP1617826B1 (en) 2003-04-18 2004-04-19 The dispersible alendronate microparticle formulation
DE602004014606T DE602004014606D1 (de) 2003-04-18 2004-04-19 Dispergierbare alendronat-mikroteilchenformulierung
AT04760192T ATE399003T1 (de) 2003-04-18 2004-04-19 Dispergierbare alendronat- mikroteilchenformulierung
DK04760192T DK1617826T3 (da) 2003-04-18 2004-04-19 Dispergerbar alendronatmikropartikelformulering
PL04760192T PL1617826T3 (pl) 2003-04-18 2004-04-19 Dyspergowalna formulacja mikrocząsteczek alendronianu
SI200430813T SI1617826T1 (sl) 2003-04-18 2004-04-19 Disperzibilen pripravek mikrodelcev alendronata
PCT/TR2004/000024 WO2004096189A2 (en) 2003-04-18 2004-04-19 The dispersible alendronate microparticle formulation
PT04760192T PT1617826E (pt) 2003-04-18 2004-04-19 Formulação dispersível de micropartículas de alendronato
CY20081100921T CY1108298T1 (el) 2003-04-18 2008-08-28 Το διασπειρομενο παρασκευασμα μικροσωματιδιων αλενδρονατης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2003/00510A TR200300510A2 (tr) 2003-04-18 2003-04-18 Dağılan alendronat mikropartikül formülasyonu

Publications (1)

Publication Number Publication Date
TR200300510A2 true TR200300510A2 (tr) 2004-11-22

Family

ID=33157605

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/00510A TR200300510A2 (tr) 2003-04-18 2003-04-18 Dağılan alendronat mikropartikül formülasyonu

Country Status (12)

Country Link
US (1) US20040208925A1 (tr)
EP (1) EP1617826B1 (tr)
AT (1) ATE399003T1 (tr)
CY (1) CY1108298T1 (tr)
DE (1) DE602004014606D1 (tr)
DK (1) DK1617826T3 (tr)
ES (1) ES2308215T3 (tr)
PL (1) PL1617826T3 (tr)
PT (1) PT1617826E (tr)
SI (1) SI1617826T1 (tr)
TR (1) TR200300510A2 (tr)
WO (1) WO2004096189A2 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101198316A (zh) * 2005-03-17 2008-06-11 伊兰制药国际有限公司 纳米微粒双膦酸盐组合物
ATE525065T1 (de) * 2006-07-10 2011-10-15 Pfleger R Chem Fab Pharmazeutische zubereitung für die orale verabreichung mit gesteuerter wirkstofffreisetzung im dünndarm und verfahren zu ihrer herstellung
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
KR101118794B1 (ko) 2009-11-10 2012-06-13 동아제약주식회사 비스포스포네이트를 함유하는 약학 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
PL181304B1 (pl) * 1994-07-22 2001-07-31 Lilly Co Eli Preparat farmaceutyczny do hamowania zmniejszania masy kosci PL PL PL PL PL PL PL PL PL PL
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
US5773429A (en) * 1996-12-11 1998-06-30 Fuisz Technologies Ltd. Drug combination for treating calcium loss
KR100400053B1 (ko) * 1997-06-11 2003-09-29 더 프록터 앤드 갬블 캄파니 향상된 상부 위장관 안전용 필름 피복 정제
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
HUP0303700A3 (en) * 2000-07-17 2006-07-28 Astellas Pharma Inc Chuo Ku Pharmaceutical composition improved in peroral absorbability
BR0209360A (pt) * 2001-05-02 2004-06-08 Novartis Ag Método de administração de bisfosfonatos por inalação no tratamento ou prevenção de reabsorção óssea e osteoporose
WO2003043641A1 (en) * 2001-11-19 2003-05-30 Nobel Ilaç Sanayii Ve Ticaret A.S. New pharmaceutical combinations prepared with alginates and biphosphonates in order to prevent gastroesophageal reflux during use of oral biphoshonates

Also Published As

Publication number Publication date
ATE399003T1 (de) 2008-07-15
WO2004096189A2 (en) 2004-11-11
US20040208925A1 (en) 2004-10-21
CY1108298T1 (el) 2014-02-12
DE602004014606D1 (de) 2008-08-07
SI1617826T1 (sl) 2008-12-31
PT1617826E (pt) 2008-09-09
DK1617826T3 (da) 2008-10-06
EP1617826B1 (en) 2008-06-25
WO2004096189A3 (en) 2005-03-03
EP1617826A2 (en) 2006-01-25
ES2308215T3 (es) 2008-12-01
PL1617826T3 (pl) 2008-11-28

Similar Documents

Publication Publication Date Title
TR200003176T2 (tr) Mide asit salgısını inhibe eden imidazo piridin türevleri
DE59501652D1 (de) Magensäure-bindende kaupastillen
ATE437896T1 (de) Flüssige dispersionspolymerzusammensetzungen, ihre herstellung und ihre verwendung
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
ATE551988T1 (de) Orale zusammensetzungen, ihre herstellung und verwendung
DE60101581D1 (de) Tablettenform zur gastrischen zurückhaltungssteigerung wasserquellfähiger mit kontrollierter freisetzung oraler dosierungsformen
CY1114620T1 (el) Φαρμακευτικη συνθεση προς υπογλωσσια χορηγηση
TR199901250T2 (tr) Tedavi amaçli ajanlar.
TR200101339T2 (tr) Potasyum kanal modülatörleri olarak 3-yer-alanlı-4-arilkinolin-2-on türevleri, 3,4-okzadiazolon türevleri
TR200300510A2 (tr) Dağılan alendronat mikropartikül formülasyonu
TR200001688T2 (tr) TTS içeren bir antioksidant.
TR200202559A2 (tr) Farmasötik terkip.
BR9901782A (pt) Forma para dosagem de nefazodona.
BRPI0507256A (pt) formulação de enzima sólida ou lìquida estabilizada, processo para a preparação de gránulo (s) contendo fosfatase, gránulo (s) contendo enzimas, processos para a preparação de uma ração animal, ou uma pré-mistura ou precursor para uma ração animal e para a preparação de uma composição, ou um apré-mistura ou um precursor adequado para nutrição humana, uso de formulação sólida e/ou lìquida estabilizada, e, processo para promover o crescimento de um animal e/ou melhorar a taxa de conversão de alimento
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
NZ510254A (en) Novel composition and use
TR201909466T4 (tr) Düşük serbest stearik asit içeren veya tespit edilebilen hiç serbest stearik asit içermeyen, stearik asitle işlenmiş kalsiyum karbonat bileşimleri ve ilgili yöntemler.
BR9814985A (pt) Partìculas inorgânicas tratadas com fosfonatossiloxano
RU2010112986A (ru) Управляемое поверхностное гелеобразование мукоадгезивных полимеров в слизистой оболочке полости рта
ATE323121T1 (de) Emulsionen von silylierten elastomeren polymeren mit hohem feststoffgehalt
ATE342935T1 (de) Titandioxidschlämme mit verbesserter stabilität
CN100384923C (zh) 一种透明质酸-壳聚糖交联生物相容材料的制备方法
BR9911067A (pt) Uso de inibidores de receptores de alfa1beta1 integrina e inibidores tgf-beta1 no tratamento de doença renal
ES2264029T3 (es) Alfa-glucanos ramificados para la gestion del peso.
BR9913389A (pt) Agentes de preparação